These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 20724682)
1. Antiretroviral therapy as HIV prevention: status and prospects. Mayer KH; Venkatesh KK Am J Public Health; 2010 Oct; 100(10):1867-76. PubMed ID: 20724682 [TBL] [Abstract][Full Text] [Related]
2. Further escalation of the global HIV/AIDS epidemic in 2005 but one million patients on antiretroviral therapy. Gupta RK Euro Surveill; 2005 Nov; 10(11):E051124.2. PubMed ID: 16794285 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention. Heendeniya A; Bogoch II Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092 [TBL] [Abstract][Full Text] [Related]
4. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?]. Supervie V Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932 [TBL] [Abstract][Full Text] [Related]
5. Pre-exposure chemoprophylaxis (PREP) as an HIV prevention strategy. Youle M; Wainberg MA J Int Assoc Physicians AIDS Care (Chic); 2003; 2(3):102-5. PubMed ID: 14556428 [TBL] [Abstract][Full Text] [Related]
6. CROI 2014: Advances in antiretroviral therapy. Taylor BS; Shalev N; Wilkin TJ Top Antivir Med; 2014 May; 22(2):616-31. PubMed ID: 24901887 [TBL] [Abstract][Full Text] [Related]
7. Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10. Thorne C; Semenenko I; Malyuta R; Addiction; 2012 Jan; 107(1):118-28. PubMed ID: 21819473 [TBL] [Abstract][Full Text] [Related]
8. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Simon V; Ho DD; Abdool Karim Q Lancet; 2006 Aug; 368(9534):489-504. PubMed ID: 16890836 [TBL] [Abstract][Full Text] [Related]
9. Does antiretroviral therapy prevent HIV transmission to sexual partners? Lalani T; Hicks C Curr HIV/AIDS Rep; 2007 May; 4(2):80-5. PubMed ID: 17547829 [TBL] [Abstract][Full Text] [Related]
10. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114 [TBL] [Abstract][Full Text] [Related]
11. The AIDS epidemic--a progress report from Mexico City. Steinbrook R N Engl J Med; 2008 Aug; 359(9):885-7. PubMed ID: 18753643 [No Abstract] [Full Text] [Related]
12. Antiretroviral use during pregnancy for treatment or prophylaxis. Sturt AS; Read JS Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886 [TBL] [Abstract][Full Text] [Related]
13. Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy. Antinori A; Ammassari A; Torti C; Marconi P; Andreoni M; Angarano G; Bonora S; Castagna A; Cauda R; Clerici M; Monforte Ad; De Luca A; Di Perri G; Galli M; Girardi E; Gori A; Lazzarin A; Lo Caputo S; Mazzotta F; Montella F; Mussini C; Perno CF; Puoti M; Rizzardini G; Rusconi S; Vullo V; Carosi G Infection; 2009 Jun; 37(3):270-82. PubMed ID: 19479193 [TBL] [Abstract][Full Text] [Related]
14. Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection. Kalapila AG; Marrazzo J Med Clin North Am; 2016 Jul; 100(4):927-50. PubMed ID: 27235622 [TBL] [Abstract][Full Text] [Related]
15. Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion. Al-Hajjar SH; Frayha HH; Al-Hazmi M; Batawi R; McIntosh K; Sax PE; Al-Thawadi S; Al-Jumaah S; Busch MP; Hanhauser E; Kuritzkes DR; Li JZ; Henrich TJ AIDS; 2014 Jun; 28(10):1539-41. PubMed ID: 24896805 [No Abstract] [Full Text] [Related]
16. Maximizing the benefits of antiretroviral therapy for key affected populations. Grubb IR; Beckham SW; Kazatchkine M; Thomas RM; Albers ER; Cabral M; Lange J; Vella S; Kurian M; Beyrer C; J Int AIDS Soc; 2014; 17(1):19320. PubMed ID: 25043380 [TBL] [Abstract][Full Text] [Related]
17. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Mimiaga MJ; Closson EF; Kothary V; Mitty JA Arch Sex Behav; 2014 Jan; 43(1):99-106. PubMed ID: 24243002 [TBL] [Abstract][Full Text] [Related]
18. A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure. Bulterys M; Vermund SH; Chen RY; Ou CY Chin Med J (Engl); 2009 Jun; 122(11):1352-5. PubMed ID: 19567150 [No Abstract] [Full Text] [Related]
19. The social construction of ARVs in South Africa. Sember R Glob Public Health; 2008; 3 Suppl 2():58-75. PubMed ID: 19288353 [TBL] [Abstract][Full Text] [Related]
20. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study. Williams BG; Gupta S; Wollmers M; Granich R Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]